Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11750)
All Articles published online
|
Publishing Process of This Article
|
Jul 28, 2022 (publication date) through Dec 2, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Leowattana W, Leowattana T. Potassium-competitive acid blockers and gastroesophageal reflux disease. World J Gastroenterol 2022; 28(28): 3608-3619 [PMID: 36161043 DOI: 10.3748/wjg.v28.i28.3608] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v28/i28/3608.htm |
| Number | Citing Articles |
| 1 |
Georges Jourdi, Jean-Sébastien Hulot, Pascale Gaussem. An update on oral antiplatelet drug interactions with proton pump inhibitors: what are the risks?. Expert Opinion on Drug Metabolism & Toxicology 2024; 20(8): 749 doi: 10.1080/17425255.2024.2378888
|
| 2 |
Xinxu Zhou, Hui Duan, Qian Li, Qiong Wang, Xiaobin Sun. Efficacy and safety of potassium-competitive acid inhibitors in the treatment of gastroesophageal reflux: a systematic review and meta-analysis. Scandinavian Journal of Gastroenterology 2024; 59(7): 788 doi: 10.1080/00365521.2024.2349638
|
| 3 |
Piotr Kucharczyk, Karolina Anna Parzęcka, Michał Jakub Symulewicz, Weronika Zań, Kinga Szczepanik, Olaf Domaradzki, Bartłomiej Kusy, Mateusz Michalak, Marta Stolińska. Innovative therapeutic strategies in the treatment of gastroesophageal reflux disease (GERD): A review of progress and perspectives. Wiadomości Lekarskie 2024; 77(6): 1271 doi: 10.36740/WLek202406124
|
| 4 |
Mujtaba Alrayah, Rajab Alzahrani, Mohammed A Alghamdi, Kholoud M Alghamdi, Faisal F Almutairi, Anwar A Alghamdi, Raghad A Alzahrani, Taif A Bajaber, Tahani F Alanazi, Haya A Alnafisah. Assessment of the Current Knowledge and Practice of General Practitioners Towards Laryngopharyngeal Reflux in Saudi Arabia. Cureus 2023; doi: 10.7759/cureus.38043
|
| 5 |
M.A. Valdovinos Díaz, M. Amieva-Balmori, R. Carmona-Sánchez, E. Coss-Adame, O. Gómez-Escudero, M. González-Martínez, F. Huerta-Iga, E. Morel-Cerda, J.M. Remes-Troche, J.L. Tamayo-de la Cuesta, G. Torres-Villalobos, L.R. Valdovinos-García, G. Vázquez-Elizondo, A.S. Villar-Chávez, J.A. Arenas-Martínez. Good clinical practice recommendations for the diagnosis and treatment of gastroesophageal reflux disease. An expert review from the Asociación Mexicana de Gastroenterología. Revista de Gastroenterología de México (English Edition) 2024; 89(1): 121 doi: 10.1016/j.rgmxen.2023.12.002
|
| 6 |
阳 高. Advances in the Treatment of Gastroesophageal Reflux Disease. Advances in Clinical Medicine 2024; 14(05): 1790 doi: 10.12677/acm.2024.1451617
|
| 7 |
Angela Tietto, Sofia Faggin, Carmelo Scarpignato, Edoardo Vincenzo Savarino, Maria Cecilia Giron. Safety of potassium-competitive acid blockers in the treatment of gastroesophageal reflux disease. Expert Opinion on Drug Metabolism & Toxicology 2024; : 1 doi: 10.1080/17425255.2024.2397433
|
| 8 |
E. A. Ortenberg, M. V. Lyapina, E. F. Dorodnyeva. Competitive proton pump inhibitors - status and Prospects of use. Experimental and Clinical Gastroenterology 2023; (4): 86 doi: 10.31146/1682-8658-ecg-212-4-86-92
|
| 9 |
Jiten P. Kothadia, Colin W. Howden. Potassium-Competitive Acid Blockers for the Treatment of Gastroesophageal Reflux Disease. Foregut: The Journal of the American Foregut Society 2024; 4(1): 7 doi: 10.1177/26345161231181357
|
| 10 |
岚 卿. Progress of Potassium-Competitive Acid Blocker Tegoprazan in the Treatment of Acid-Related Diseases. Advances in Clinical Medicine 2024; 14(08): 117 doi: 10.12677/acm.2024.1482189
|
| 11 |
Eunsol Yang, Inyoung Hwang, Sang Chun Ji, John Kim, SeungHwan Lee. Population pharmacokinetic analysis of zastaprazan (JP‐1366), a novel potassium‐competitive acid blocker, in patients and healthy volunteers. CPT: Pharmacometrics & Systems Pharmacology 2024; doi: 10.1002/psp4.13228
|
| 12 |
S. V. Tikhonov, E. N. Kareva, S. Yu. Serebrova, G. F. Vasilenko, M. K. Vasilyeva, S. A. Makhortova, N. V. Pavlova. New achievements of pharmacology for practical medicine in prevention and therapy of acid-dependent diseases. Meditsinskiy sovet = Medical Council 2023; (8): 33 doi: 10.21518/ms2023-133
|
| 13 |
Jeremy Klein, Robert T. Kavitt. Gastroesophageal Reflux Disease. 2023; : 61 doi: 10.1007/978-3-031-48241-0_8
|
| 14 |
M.A. Valdovinos-Diaz, M. Amieva-Balmori, R. Carmona-Sánchez, E. Coss-Adame, O. Gómez-Escudero, M. González-Martínez, F. Huerta-Iga, E. Morel-Cerda, J.M. Remes-Troche, J.L. Tamayo-de la Cuesta, G. Torres-Villalobos, L.R. Valdovinos-García, G. Vázquez-Elizondo, A.S. Villar-Chávez, J.S. Arenas-Martínez. Recomendaciones de buena práctica clínica en el diagnóstico y tratamiento de la enfermedad por reflujo gastroesofágico. Revisión por expertos de la Asociación Mexicana de Gastroenterología. Revista de Gastroenterología de México 2024; 89(1): 121 doi: 10.1016/j.rgmx.2023.12.002
|
| 15 |
Shupeng Zou, Mengling Ouyang, Qian Cheng, Xuan Shi, Minghui Sun. Acid‐suppressive drugs: A systematic review and network meta‐analysis of their nocturnal acid‐inhibitory effect. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2024; 44(2): 171 doi: 10.1002/phar.2899
|
| 16 |
Su Il Kim, Young Chan Lee, Wonjae Cha, Ah Ra Jung, Jeon Yeob Jang, Jeong-Seok Choi, Dong Kun Lee, Hwan Ho Lee, Min Su Kwon, Yoon Se Lee, Young-Gyu Eun. Efficacy and safety of fexuprazan in patients with symptoms and signs of laryngopharyngeal reflux disease: a randomized clinical trial. European Archives of Oto-Rhino-Laryngology 2024; 281(11): 5873 doi: 10.1007/s00405-024-08877-6
|